May 15, 2025
Adovate Accepted into JLABS, Global Incubator Network
Charlottesville, VA – May 15, 2025 – Adovate, LLC (“Adovate” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics targeting the adenosine receptors, today announced its acceptance into Johnson & Johnson’s global incubator network, JLABS.